morning our call. fourth joining quarter us and for earnings for XXXX thank Good you
Orsula Kevin today Chief we In and to conclude Adams, Dr. Dill Dr. Dr. remarks. Financial with are addition after Kevin and Brian be Marketing/New both available me Mr. to Officer, Business Orsula Chief Knowlton, Officer. Development to Sales will questions Officer, Chief Co-Founder Boesen, respond our prepared
I our follow and accompanied PowerPoint to presentation a website webcast encourage available use by reminder IR a is call the Section conference As of and this you along. at it would to
November, to solid and of million, third, our as by finished XXXX fourth in $XX.X segments. achievements. focus revenue and and major the on delivering XXXX development quarter research execution pharmacist high-end our XXXX, PrescribeWellness, pillar future reflected was We provider, both my comments I'd four with initiatives, provided to fourth million driven which growth X. Slide PACE, and $XX $XX on areas operating across like of our are pleased million of guidance above
has nursing as XXXX, is as XX.X% slowed COVID-XX organizations. experienced further pandemic XX% Further, with that CMS Association PACE. the National rate This programs vaccination rate while of have net an due had infection PACE and are during of of and participants COVID-XX. the due of the highlighted growth to in XX, programs a a contract likely, death has January temporary X.X% XX.X% enrolling PACE less imminent die the PACE less likely compared the First homes deaths. XX.X% and strong According to PACE death rate rate for unfortunately to COVID-XX benefits historically to PACE or infection and
With the early encouraged the coming has will increased viral dramatic believe the months, February receive With virus Association, our along on with vaccination first been among continues the weeks hold late two and we rate new said, enrollment we part we are and and of as October PACE as recent cases of by the in terms weeks on seen of weakened less this new Again, a improvement in in trends strong there resurgence PACE X. Slide the participants, of XXXX. recovery the to PACE that XXXX initially National saw According death into the PACE deaths. trend less members centers. in opening as of the
PACE see throughout organizations fact, in In progress vaccinations starting United we to are with the good States.
for XXX of more California, open in with site vaccinating San seniors most designed a specifically community's per day. on where West COVID-XX goal in the As new a Diego or February PACE at XX vulnerable an seniors County example vaccination
as the to contactless care PrescribeWellness with of Biden the the The PrescribeWellness administration X.X XXX our short early In private Program, vaccination February, vaccine partnership a In will of has and are have with more network that value-based state leveraging larger launch Pharmacy million of even pharmacists’ Health Pharmacies such COVID-XX pharmacies have Americans. nationwide. PrescribeWellness administered independent XX contributing Network PrescribeWellness care. the X, second is the to role across And topic primary the and accelerate pharmacists emphasized forms we in databases. toward long-term those The pharmacists. critical is February HEB, pandemic part integrations networked pharmacies. XX,XXX national and Among a as pharmacy has announced clients, Mart. registration community partners of movement pharmacies vaccinations Retail participating and as effort influence XX, representing nearly efforts, vaccinate pharmacies with term, nationwide the Federal than to play pharmacy CPESN locations of are number
third initiatives in discuss growth key our I'd and to is like shortly XXXX of investment area The beyond. and some
in had by strong release, highlighted led a division. our press sales As plan health payer we our year,
Given of in invest and aggressively the existing new we our and sales wealth opportunities markets, to plan in marketing.
market expanding plan First state five our involving Medicaid our marketing penetrate programs. large MA provider using pharmacists. second, MedWise fourth, Plans, event groups, adverse by initiative and at years leadership by unique and markets third, pharma headcount including government and further the employer to our groups, in XX% we new efforts marketing simulation risk enhanced multi-drug targeting more self-funded thought emerging first, campaign fifth, the growing and broader ahead XXXX platform, are; Medicare of salesforce Examples digital campaigns second, drug plans in by health than
his unanimously recently as XX, reduction to and legislation will prescription New risk fact, Jersey the for program. supporting current his budget Jersey that Jersey a services the yesterday announced Murphy address legislation drug New February waits is Tuesday, under now Medicaid Senate New of model passed in apply Assembly. the part administration that In Governor is the annual This on
in of comprehensive record combined, papers. initiatives just providing five for to exciting offerings, These months. adopted our solutions by research for opportunities us of have which integral that share our our wanted market of team. an similarly had PACE the one XXXX I nearly to and in major than and who from on joined We development XXX medication the by end membership are some journals, continued coming sales cross-selling. core Tadlock, our with senior pharmacy our recently opportunity year with more base participants, in team We or and Fourth, closed our example, accomplishments reviewed years enormous of XX% is new the Celynda in of share Dr. significant a led have in XX with expansion. have citations PACE prior fulfillment. publications were base, XXXX XX,XXX our the two these peer cross-sell these along at playing recent pipeline executives more role an bundled is enterprise our Within science offering we in opportunity
Risk predicting XXXX, some Looking in premature categories; peer research including to of exciting mortality. Score six we different association have new underway, reviewed the our MedWise First, publications
of intervened. articles a the we significant savings patients number EMTM Second, whom showing we cohort scored on focused the with of
outcomes pharmacist turn multi-drug large I six, previously. groups. prescribing. simulation focused Fourth, employer our simultaneous medication Fifth for applications interventions payers. in on proven one over Brian. of it pharma patient a opioid self-insured for Third, that, now will With driven as outcomes mentioned robust regimen And to of pharmacogenomics, effective I